We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.01B
AUM Growth
-$362M
Cap. Flow
+$68.7M
Cap. Flow %
1.14%
Top 10 Hldgs %
34.55%
Holding
1,204
New
32
Increased
655
Reduced
474
Closed
37
Avg Time Held
6 quarters
Top 10 Avg Time Held
6.1 quarters
Top 20 Avg Time Held
4.5 quarters

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$11.8M
2
D icon
Dominion Energy
D
+$8.67M
3
AMD icon
Advanced Micro Devices
AMD
+$7.97M
4
TSLA icon
Tesla
TSLA
+$7.83M
5
AVGO icon
Broadcom
AVGO
+$7M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$11M
2
SRE icon
Sempra
SRE
+$9.56M
3
XLNX
Xilinx Inc
XLNX
+$8.68M
4
REG icon
Regency Centers
REG
+$8.65M
5
ADBE icon
Adobe
ADBE
+$7.67M

Sector Composition

Rank Sector Weight
1 Technology 31.41%
2 Consumer Discretionary 14.27%
3 Healthcare 11.61%
4 Financials 10.56%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SHW icon
101
Sherwin-Williams
SHW
$77.7B
$10.1M 0.17%
40,538
+549
+1% +$152K
2020 Q2
7 quarters
ITW icon
102
Illinois Tool Works
ITW
$75.5B
$10.1M 0.17%
48,145
+424
+0.9% +$94.9K
2020 Q2
7 quarters
MRNA icon
103
Moderna
MRNA
$85.3B
$10M 0.17%
58,210
-2,998
-5% -$505K
2020 Q2
7 quarters
SYK icon
104
Stryker
SYK
$108B
$10M 0.17%
37,404
+795
+2% +$206K
2020 Q2
7 quarters
A icon
105
Agilent Technologies
A
$48.3B
$9.95M 0.17%
75,179
-445
-0.6% -$61.2K
2020 Q2
7 quarters
TSN icon
106
Tyson Foods
TSN
$18.8B
$9.9M 0.16%
110,502
-1,225
-1% -$112K
2020 Q2
7 quarters
MDT icon
107
Medtronic
MDT
$118B
$9.9M 0.16%
89,228
+3,141
+4% +$332K
2020 Q2
7 quarters
FDX icon
108
FedEx
FDX
$69.2B
$9.84M 0.16%
42,516
+15,968
+60% +$3.75M
2020 Q2
7 quarters
RTX icon
109
RTX Corp
RTX
$252B
$9.54M 0.16%
96,297
+2,306
+2% +$219K
2020 Q2
7 quarters
CI icon
110
Cigna
CI
$74.9B
$9.4M 0.16%
39,242
-603
-2% -$141K
2020 Q2
7 quarters
PM icon
111
Philip Morris
PM
$315B
$9.39M 0.16%
99,914
+2,495
+3% +$250K
2020 Q2
7 quarters
REGN icon
112
Regeneron Pharmaceuticals
REGN
$78.5B
$9.36M 0.16%
13,402
+202
+2% +$128K
2020 Q2
7 quarters
MTD icon
113
Mettler-Toledo International
MTD
$31.3B
$9.31M 0.15%
6,779
-50
-0.7% -$72.2K
2020 Q2
7 quarters
KLAC icon
114
KLA
KLAC
$248B
$9.3M 0.15%
254,180
-69,360
-21% -$2.59M
2020 Q2
7 quarters
EQIX icon
115
Equinix
EQIX
$102B
$9.26M 0.15%
12,491
+169
+1% +$122K
2020 Q2
7 quarters
MCO icon
116
Moody's
MCO
$81.5B
$9.2M 0.15%
27,268
+550
+2% +$185K
2020 Q2
7 quarters
ADI icon
117
Analog Devices
ADI
$197B
$9.18M 0.15%
55,565
-27
-0% -$4.37K
2020 Q2
7 quarters
CTAS icon
118
Cintas
CTAS
$81.5B
$9.13M 0.15%
85,896
+324
+0.4% +$31.5K
2020 Q2
7 quarters
ILMN icon
119
Illumina
ILMN
$41.8B
$9.1M 0.15%
26,777
+347
+1% +$117K
2020 Q2
7 quarters
IDXX icon
120
Idexx Laboratories
IDXX
$41.3B
$9.09M 0.15%
16,623
+145
+0.9% +$76.3K
2020 Q2
7 quarters
AON icon
121
Aon
AON
$58.3B
$9.03M 0.15%
27,730
+475
+2% +$138K
2020 Q2
7 quarters
CME icon
122
CME Group
CME
$99.7B
$8.93M 0.15%
37,551
+14,627
+64% +$3.44M
2020 Q2
7 quarters
ALGN icon
123
Align Technology
ALGN
$9.98B
$8.93M 0.15%
20,485
+68
+0.3% +$33.1K
2020 Q2
7 quarters
EXR icon
124
Extra Space Storage
EXR
$28.3B
$8.72M 0.15%
42,402
-216
-0.5% -$42.9K
2020 Q2
7 quarters
RHI icon
125
Robert Half
RHI
$3.52B
$8.37M 0.14%
73,304
-438
-0.6% -$50.5K
2020 Q2
7 quarters
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q1 2022 Portfolio in Review

As of Q1 2022, Xponance held 1,204 positions worth $6.01B, down 5.7% from $6.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Xponance's Q1 2022 filing shows 32 new, 655 increased, 474 reduced and 37 closed positions. Its largest new stake was Apollo Global Management: 28,803 shares worth $1.78M. The largest sale was Exelon, an estimated $11M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q1 2022 buy was Apollo Global Management: 28,803 shares worth $1.78M.
  • Xponance added most to Prologis in Q1 2022, an estimated $11.8M increase.
  • Xponance's biggest Q1 2022 reduction was Exelon, cutting an estimated $11M.
  • Xponance fully exited Xilinx Inc in Q1 2022, selling an estimated $8.68M.
  • Xponance's ten largest holdings make up 35% of its $6.01B portfolio in Q1 2022.
  • Xponance opened 32 new positions and closed 37 in Q1 2022.
  • Xponance's portfolio value fell 5.7% quarter-over-quarter to $6.01B.

Based on Xponance's 13F filing for Q1 2022, filed 20 Apr 2022.